NCT00212043View on ClinicalTrials.gov

Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

February 29, 2004

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG

carboplatin and gemcitabine

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

National University Hospital, Singapore

OTHER

NCT00212043 - Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma | Biotech Hunter | Biotech Hunter